SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-22-016671
Filing Date
2022-08-11
Accepted
2022-08-11 08:30:49
Documents
62
Period of Report
2022-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q gmtx-20220630.htm   iXBRL 10-Q 2058830
2 EX-31.1 gmtx-ex31_1.htm EX-31.1 17842
3 EX-31.2 gmtx-ex31_2.htm EX-31.2 18022
4 EX-32.1 gmtx-ex32_1.htm EX-32.1 26957
  Complete submission text file 0000950170-22-016671.txt   6527493

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT gmtx-20220630_lab.xml EX-101.LAB 401110
6 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT gmtx-20220630_def.xml EX-101.DEF 160638
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT gmtx-20220630_cal.xml EX-101.CAL 33366
8 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT gmtx-20220630_pre.xml EX-101.PRE 279845
9 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT gmtx-20220630.xsd EX-101.SCH 54847
56 EXTRACTED XBRL INSTANCE DOCUMENT gmtx-20220630_htm.xml XML 902064
Mailing Address 300 ONE KENDALL SQUARE, 3RD FLOOR CAMBRIDGE MA 02139
Business Address 300 ONE KENDALL SQUARE, 3RD FLOOR CAMBRIDGE MA 02139 (617) 401-4400
Gemini Therapeutics, Inc. /DE (Filer) CIK: 0001816736 (see all company filings)

IRS No.: 851613057 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39438 | Film No.: 221153839
SIC: 2834 Pharmaceutical Preparations